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Abstract
How small heat shock proteins (sHsps) might empower proteostasis networks to control beneficial prions or disassemble
pathological amyloid is unknown. Here, we establish that yeast sHsps, Hsp26 and Hsp42, inhibit prionogenesis by the [PSI
+]
prion protein, Sup35, via distinct and synergistic mechanisms. Hsp42 prevents conformational rearrangements within
molten oligomers that enable de novo prionogenesis and collaborates with Hsp70 to attenuate self-templating. By contrast,
Hsp26 inhibits self-templating upon binding assembled prions. sHsp binding destabilizes Sup35 prions and promotes their
disaggregation by Hsp104, Hsp70, and Hsp40. In yeast, Hsp26 or Hsp42 overexpression prevents [PSI
+] induction, cures
[PSI
+], and potentiates [PSI
+]-curing by Hsp104 overexpression. In vitro, sHsps enhance Hsp104-catalyzed disaggregation of
pathological amyloid forms of a-synuclein and polyglutamine. Unexpectedly, in the absence of Hsp104, sHsps promote an
unprecedented, gradual depolymerization of Sup35 prions by Hsp110, Hsp70, and Hsp40. This unanticipated amyloid-
depolymerase activity is conserved from yeast to humans, which lack Hsp104 orthologues. A human sHsp, HspB5, stimulates
depolymerization of a-synuclein amyloid by human Hsp110, Hsp70, and Hsp40. Thus, we elucidate a heretofore-
unrecognized human amyloid-depolymerase system that could have applications in various neurodegenerative disorders.
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Introduction
Amyloid fibers are thread-like protein polymers with cross-b
structure. These unusually stable, self-templating structures were
first identified in various systemic amyloidoses and neurodegen-
erative disorders such as Alzheimer’s disease [1]. In isolation,
many proteins can form amyloid fibers, suggesting that amyloi-
dogenesis is an intrinsic property of polypeptides [1–3]. Indeed,
amyloid conformers have been captured during evolution for
various beneficial purposes, including prion-based transmission of
advantageous phenotypes, long-term memory formation, melano-
some biogenesis, drug resistance, and biofilm formation [4–14].
Moreover, as stable self-organizing polymers, amyloids are
interesting nanomaterials [15–19]. Thus, in diverse fields there is
an urgent need to understand how we can promote or reverse
amyloidogenesis as necessary.
We hypothesized that small heat shock proteins (sHsps) might
enable control of amyloidogenic trajectories. sHsps are the most
widespread family of molecular chaperones [20,21]. sHsps protect
cells from diverse environmental stresses by suppressing amor-
phous aggregation of denatured proteins [20–23]. All sHsps
harbor a conserved C-terminal a-crystallin domain of ,90
residues, but are otherwise diverse in size and sequence. Typically,
sHsps form large dynamic oligomers and function as ATP-
independent chaperones that bind denatured proteins to prevent
aggregation [20–23]. sHsps maintain proteins in a soluble form
that can be reactivated by Hsp70 [24–26].
The yeast cytosol harbors two sHsps: Hsp42 and Hsp26. Both form
large dynamic oligomers of 24 subunits [27–30]. Hsp42 is more
abundant and prevents protein aggregation at physiological and heat
shock temperatures [28]. By contrast, Hsp26 is activated as a
chaperone at elevated temperatures via complex changes in the
quaternary dynamics of its oligomer [27,29,31,32]. Hsp26 and Hsp42
display overlapping and broad substrate specificity [28]. Incorporation
of Hsp26 into denatured aggregates can promote their dissolution and
renaturation by Hsp104 and Hsp70 [26,33]. However, if Hsp26 is
added to preformed denatured aggregates, then it cannot assist
Hsp104 and Hsp70 [33]. Much less is known about Hsp42, which
might be involved in aggregate partitioning in vivo [34]. Whether
Hsp42 interacts directly with Hsp104 or Hsp70 is unknown.
Despite these advances in understanding how sHsps handle
denatured proteins, much less is known about how sHsps might
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inhibit different steps in amyloidogenesis of various disease
proteins, such as a-synuclein (a-syn), polyglutamine, or Ab40
[23,33,35–38]. Yet it is unknown whether sHsps enable the
proteostasis machinery to disassemble pathological amyloid.
Furthermore, it is unknown whether sHsps regulate beneficial
amyloid.
In this study, we address these issues by first employing the yeast
translation termination factor, Sup35 (Figure 1). Sup35 forms
infectious amyloids (prions) that transmit heritable reductions in
translation termination fidelity and comprise the yeast prion [PSI
+]
[8]. [PSI
+]-encoded reductions in translation termination fidelity
confer phenotypic diversity and selective advantages to yeast in
diverse environments [8,10,11,13], but can be deleterious in other
settings [39]. Sup35 is a valuable paradigm for studying prion-
folding events, with analytical tools that are unavailable for other
amyloids or prions. Indeed, these tools have helped clarify how
Sup35 prions assemble [40,41]. They have also revealed various
aspects of Sup35 prion structure at the resolution of spatial
arrangements of individual amino acids involved in inter- and
intra-molecular contacts (Figure 1) [40–42]. These tools provide
unique opportunities to establish a detailed understanding of how
sHsps affect prion assembly and disassembly.
The two N-terminal domains of Sup35, termed NM, confer all
the properties needed to form a stable prion in yeast (Figure 1) [8].
In isolation, NM spontaneously forms prions by a well-defined
mechanism that involves a lag phase and assembly phase
[40,43,44]. Early in lag phase, NM partitions between a
monomeric (,90% total NM) and oligomeric (,10% total NM)
pool (Figure 1, step 1) [40,43,45,46]. NM monomers are largely
unstructured and populate multiple transient conformations [47].
However, the specific intermolecular contacts required for prion
formation ultimately form in molten NM oligomers. NM
monomers within structurally fluid oligomers gradually reorganize
(Figure 1, step 2) to form amyloidogenic oligomers (Figure 1, step
3), which are structurally distinct to fibers [40,43,48,49]. The
intermolecular contacts that define prions form very rapidly once
these obligate, transient intermediates appear (Figure 1, step 4)
[40–42,48,49]. Amyloid fibers then seed their own rapid
bidirectional assembly by capturing and converting monomers to
the cross-b form (Figure 1, step 5) [43,46,50]. Short prion
recognition elements within the N-terminal domain (N), termed
the ‘‘Head’’ and ‘‘Tail’’, are proposed to make homotypic
intermolecular contacts in assembled prions [40–42,51,52]. Thus,
prions are maintained by alternating Head-to-Head and Tail-to-
Tail contacts that separate a central core (Figure 1). Both the Head
and Tail regions can nucleate prion assembly, although the rate-
limiting step of lag phase is the establishment of the Head-to-Head
contact [40–42,51]. This well-defined sequence of prion-folding
events provides an unparalleled opportunity to understand how
sHsps affect prion formation at a molecular level.
How Hsp26 and Hsp42 might affect prion-folding events in
yeast is unclear. Both Hsp26 and Hsp42 are found to be associated
with ex vivo SDS-resistant prion aggregates [53], but deletion of
Hsp26 does not affect [PSI
+] propagation [12] and overexpression
of Hsp26 or Hsp42 does not cure [RNQ
+] [33]. However, beyond
these observations nothing is known about how these sHsps might
affect prion-folding events. It is also unclear whether sHsps
contribute to the dissolution of amyloid or prion conformers by the
proteostasis network. In yeast, the protein disaggregase and AAA+
ATPase, Hsp104, can rapidly disassemble amyloid conformers
[48,49,54–58]. Overexpression of Hsp26 or Hsp42 together with
Hsp104 can increase soluble levels of polyglutamine in yeast, but
whether this reflected enhanced disaggregation or inhibition of
aggregation remains unknown [33]. Curiously, metazoan proteos-
tasis networks lack an Hsp104 homologue [59]. Thus, it is unclear
how amyloid dissolution is catalyzed in these systems [60]. We
have recently defined a mammalian disaggregase machinery
composed of Hsp110 (Apg-2), Hsp70 (Hsc70 or Hsp70), and
Hsp40 (Hdj1), which resolves denatured aggregates, but does not
rapidly remodel amyloid [61]. Yet amyloid fibers are dynamic
entities and monomers at fiber ends can slowly dissociate and
rapidly reassociate [62–68]. Whether proteostasis networks capi-
talize on this molecular recycling to promote gradual amyloid
depolymerization is unknown. Here, we define how sHsps regulate
beneficial Sup35 prions and potentiate amyloid dissolution.
Results
Hsp26 and Hsp42 Synergize to Inhibit Spontaneous
Sup35 Prionogenesis
Using complementary methods, including Thioflavin-T (ThT)
fluorescence and SDS-resistance, we demonstrated that Hsp42
potently inhibited (IC50,0.67 mM of Hsp42 monomer) spontane-
ousNM fibrillization (Figure2A,Bbluemarkers).Markedinhibition
was observed at a ratio of NM:Hsp42 of 10:1 and assembly was
abolishedat an NM:Hsp42ratio of1.67:1(Figure 2A,B). Hsp26 also
inhibited (IC50,1.1 mM) spontaneous NM fibrillization
(Figure 2A,B red markers). Hsp26 was not as effective as Hsp42,
but inhibition was observed at a ratio of NM:Hsp26 of 4:1
(Figure 2A,B). A 5-fold molar excess of Hsp26 was needed to
completely block NM fibrillization. These inhibitory effects truly
precluded prion formation because NM incubated in the presence
of sHsps failed to transform [psi
2] cells to [PSI
+] (Figure 2C).
Typically, sHsps bind 1 substrate per ,2–3 sHsp monomers
[24,27]. Thus, the strong inhibition at substoichiometric concen-
trations indicates that the sHsps might inhibit a rare or transient
NM conformer that is critical for prion formation.
Remarkably, the inhibitory activities of Hsp26 and Hsp42 were
synergistic.Thecombination ofanequimolarmixture ofHsp26 and
Hsp42 was a more potent inhibitor (IC50,0.16 mM, i.e. 0.08 mMo f
Author Summary
Amyloid fibers are protein aggregates that are associated
with numerous neurodegenerative diseases, including
Parkinson’s disease, for which there are no effective
treatments. They can also play beneficial roles; in yeast,
for example, they are associated with increased survival
and the evolution of new traits. Amyloid fibers are also
central to many revolutionary concepts and important
questions in biology and nanotechnology, including long-
term memory formation and versatile self-organizing
nanostructures. Thus, there is an urgent need to under-
stand how we can promote beneficial amyloid assembly,
or reverse pathogenic assembly, at will. In this study, we
define the mechanisms by which small heat-shock proteins
synergize to regulate the assembly and disassembly of a
beneficial yeast prion. We then exploit this knowledge to
discover an amyloid depolymerase machinery that is
conserved from yeast to humans. Remarkably, the human
small heat shock protein, HspB5, stimulates Hsp110,
Hsp70, and Hsp40 chaperones to gradually depolymerize
amyloid fibers formed by a-synuclein (which are implicat-
ed in Parkinson’s disease) from their ends on a biologically
relevant timescale. This newly identified and highly
conserved amyloid-depolymerase system could have
important therapeutic applications for various neurode-
generative disorders.
sHsps Potentiate Amyloid Dissolution
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Hsp26 and Hsp42 also synergized to inhibit spontaneous priono-
genesis of full-length Sup35 (Figure 2D). To the best of our
knowledge, this is the first example of two distinct sHsps working
together in a synergistic manner to prevent prion formation.
Hsp26 and Hsp42 Inhibit De Novo Sup35 Prionogenesis
by Distinct Mechanisms
The synergistic inhibition of Sup35 prionogenesis by Hsp26 and
Hsp42 suggested that the two sHsps might inhibit prion formation
by distinct mechanisms. The ability of the sHsps to abrogate prion
formation at substoichiometric concentrations also suggested
interference with a specific conformer or intermediate that is
initially present at low concentrations. Two non-mutually exclu-
sive possibilities emerge. First, sHsps might mask the ends of de novo
formed NM fibers and thus prevent seeded assembly (Figure 1,
step 5). Second, sHsps might antagonize the formation (Figure 1,
step 1) or reorganization (Figure 1, steps 2–4) of transient molten
oligomers. Only a small fraction (,10%) of the total NM accesses
molten oligomeric forms [45], which are obligate reaction
intermediates for spontaneous fibrillization (Figure 1) [48,49].
These malleable NM oligomers possess a hydrodynamic radius of
50–130 nm, form extremely rapidly, and can be recovered by
ultracentrifugation [45,55]. Importantly, neither Hsp26 nor
Hsp42 alone or in combination inhibited the formation (Figure 1,
step 1) of NM oligomers (Figure 3A). By contrast, the combination
of Ssa1 (an Hsp70) and Ydj1 (an Hsp40) inhibited oligomer
formation (Figure 3A) [55].
After their initial formation, molten NM oligomers gradually
reorganize into amyloidogenic forms (Figure 1, steps 2 and 3) that
ultimately elicit assembly phase (Figure 1, step 4). This maturation
process can be tracked using single cysteine NM mutants labeled
with acrylodan at specific positions [40,41]. Sequestration of
labeled sites from solvent yields increases in acrylodan fluores-
cence. Specific portions of N (,residues 21–106) gradually
become solvent inaccessible in molten oligomers prior to fiber
assembly (Figure 1, steps 2 and 3). This process begins immediately
and the maximal increase in acrylodan fluorescence signals the
end of lag phase and the start of assembly phase [40]. To
determine whether Hsp26 or Hsp42 interfered with this process
we utilized NM with acrylodan attached to cysteines replacing
Asn21, Gln38, Gly96, or Tyr106. These mutated and labeled NM
variants retain wild-type assembly kinetics and ability to access
infectious forms [40–42]. We measured acrylodan fluorescence
after 15 min, when the assembly reaction remained in lag phase
(Figure 3B). Hsp26 had only a slight inhibitory effect on increases
in acrylodan fluorescence at all positions tested, suggesting that
Hsp26 does not interfere with oligomer maturation (Figure 3B;
Figure 1, steps 2 and 3). By contrast, Hsp42 inhibited increases in
acrylodan fluorescence at all positions tested (Figure 3B). We
conclude that Hsp42 inhibits spontaneous NM fibrillization by
preventing the maturation of molten NM oligomers (Figure 1,
steps 2 and 3). Remarkably, Hsp26 and Hsp42 together caused the
greatest inhibition of increased acrylodan fluorescence (Figure 3B).
Next, we determined how Hsp42 or Hsp26 affected an obligate
on-pathway oligomeric intermediate in spontaneous Sup35
Figure 1. Mechanism of Sup35 prion assembly. Sup35 is composed of a C-terminal GTPase domain (amino acids 254–685, black) that confers
translation termination activity, a highly charged middle domain (M, amino acids 124–253, dark grey), and a prionogenic N-terminal domain (N,
amino acids 1–123, light grey) enriched in glutamine, asparagine, tyrosine, and glycine. Together N and M (NM) confer all the properties needed to
form a stable prion in yeast [94]. Hence, NM is termed the prion domain. Within N, prion recognition elements termed the ‘‘Head’’ (red) and ‘‘Tail’’
(green), which flank a ‘‘Central Core’’ (blue), play important roles in prionogenesis. After a lag phase (steps 1–3), Sup35 prions assemble rapidly (steps
4 and 5). Prion recognition elements within N make homotypic intermolecular contacts such that Sup35 prions are maintained by an alternating
sequence of Head-to-Head (red) and Tail-to-Tail (green) contacts. The Central Core (blue) is sequestered by intramolecular contacts. The amino acids
that comprise the Head, Core, and Tail region when NM is assembled at 25uC are indicated. The steps antagonized by Hsp26 and Hsp42 are indicated.
doi:10.1371/journal.pbio.1001346.g001
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detected by the conformation-specific antibody A11 [48,49,69].
This oligomeric species is most abundant at the end of lag phase
and then rapidly disappears during assembly phase (Figure 1)
[48,49]. We performed a kinetic experiment where NM assembly
was initiated for 10 min at which time either buffer, Hsp26, or
Figure 2. Hsp26 and Hsp42 synergize to inhibit spontaneous Sup35 prionogenesis. (A, B) NM (5 mM) was incubated at 25uC with agitation
for 6 h in the presence of increasing concentrations of BSA, Hsp26, Hsp42, or Hsp26 and Hsp42 (0–5 mM). For the mixture of Hsp26 and Hsp42, a 1:1
ratio was employed. Thus, a concentration of 2 mM on the x-axis reflects 1 mM Hsp26 and 1 mM Hsp42. Fibrillization was measured by Thioflavin-T
(ThT) fluorescence (A) or by determining the amount of SDS-resistant NM (B). Values represent means6SD (n=3). (C) NM (5 mM) was assembled at
25uC with agitation for 6 h in the absence or presence of Hsp26 (0.6 mMo r3mM), Hsp42 (0.6 mMo r3mM), or Hsp26 and Hsp42 (0.3 mM or 1.5 mMo f
each). Reaction products were concentrated and transformed into [psi
2] cells. No NM and soluble NM served as negative controls. The proportion of
[PSI
+] colonies was then determined. Values represent means6SD (n=3). (D) Sup35 (5 mM) was incubated at 25uC with agitation for 6 h in the
presence of increasing concentrations of BSA, Hsp26, Hsp42, or Hsp26 and Hsp42 (0–5 mM). For the mixture of Hsp26 and Hsp42, a 1:1 ratio was
employed. Thus, a concentration of 2 mM on the x-axis reflects 1 mM Hsp26 and 1 mM Hsp42. Fibrillization was measured by ThT fluorescence. Values
represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g002
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PLoS Biology | www.plosbiology.org 4 June 2012 | Volume 10 | Issue 6 | e1001346Figure 3. Hsp26 and Hsp42 inhibit de novo Sup35 prionogenesis by distinct mechanisms. (A) NM (5 mM) was rotated for 5 min (80 rpm)
in the absence or presence of Hsp26 (3 mM), Hsp42 (3 mM), or Ssa1 plus Ydj1 (3 mM). Oligomeric NM was recovered by centrifugation at 436,000 g for
30 min, resolved by SDS-PAGE, Coomassie stained, and the amount in the pellet fraction determined. Values represent means6SD (n=3). (B)
sHsps Potentiate Amyloid Dissolution
PLoS Biology | www.plosbiology.org 5 June 2012 | Volume 10 | Issue 6 | e1001346Hsp42 were added (arrow in Figure 3C,D) and the reaction was
then allowed to continue. After 10 min, A11-reactive species
had already accumulated (Figure 3C), whereas no fibers had
assembled as determined by the lack of ThT fluorescence
(Figure 3D). Addition of buffer after 10 min had no effect on
assembly and A11-reactive species continued to accumulate
until the end of lag phase (,30 min, Figure 3C, grey markers).
A11-reactive species then rapidly declined as fiber assembly
initiated (,40 min, compare grey markers in Figure 3C to black
markers in Figure 3D). Addition of Hsp42 after 10 min caused a
rapid disappearance of A11-reactive species (Figure 3C, cyan
markers) and fiber assembly was blocked (Figure 3D, blue
markers). Thus, Hsp42 reversed the formation of A11-reactive
conformers.
By contrast, addition of Hsp26 had no effect on the
accumulation of A11-reactive species during lag phase or their
rapid decline after 40 min (Figure 3C, orange markers). Yet very
little fiber assembly occurred (Figure 3D, red markers). Thus, in
contrast to Hsp42, Hsp26 does not inhibit or reverse oligomer
maturation events (Figure 1, steps 1–4). Rather, these data suggest
that Hsp26 inhibits the growth of newly formed fibers (Figure 1,
step 5). Indeed, electron microscopy revealed that a few very short
fibers assembled in the presence of Hsp26 (arrow in Figure 3E). By
contrast, oligomeric structures persisted in the presence of Hsp42,
or Hsp26 and Hsp42 (Figure 3E).
To pinpoint which steps of Sup35 prionogenesis are antago-
nized by Hsp42 or Hsp26, we experimentally bypassed the
requirement for oligomer maturation in spontaneous prion
formation (Figure 1, steps 2–4). Thus, we crosslinked single
cysteine NM mutants in specific positions with the flexible 11 A ˚
crosslinker: 1,4-bis-maleimidobutane (BMB). NM that is BMB-
crosslinked at cysteines at position Gly25 or Gly31 assembles
into fibers without a detectable lag phase [40,41]. Hsp26 or
Hsp42 potently inhibited the assembly of uncrosslinked NM, and
the combination of Hsp26 and Hsp42 was the most effective
(Figure 3F). By contrast, Hsp26 but not Hsp42 inhibited
assembly of NM that was BMB-crosslinked at position 25 or
31 (Figure 3F). The combination of Hsp26 and Hsp42 was less
effective against NM that had been BMB-crosslinked at position
25 or 31 (Figure 3F). These data suggest that Hsp26 selectively
antagonizes events after lag phase (Figure 1, step 5), whereas
Hsp42 selectively antagonizes oligomer-remodeling events dur-
ing lag phase (Figure 1, steps 2–4). Thus, Hsp26 antagonizes
events that occur after prion recognition elements have initially
formed intermolecular contacts, whereas Hsp42 prevents initial
formation of these contacts. These data suggest that Hsp26 and
Hsp42 synergize to directly antagonize Sup35 prionogenesis
prior to intermolecular contact formation by prion recognition
elements.
Hsp26 and Hsp42 Inhibit Sup35 Prion Formation In Vivo
These findings suggested that Hsp26 and Hsp42 might
antagonize [PSI
+] induction in vivo. Prion nucleation involves
protein–protein interactions [40,43]. Thus, [PSI
+] induction
frequency is very low unless Sup35 or NM is overexpressed
[70,71]. Indeed, when Sup35 was transiently overexpressed, [PSI
+]
induction increased from barely detectable levels (,1 in 1,000) to
,20% of cells (Figure 4A). [PSI
+] induction was modestly
increased by ,1.3-fold in Dhsp26 cells and ,1.6-fold in Dhsp42
cells (Figure 4A). In a double deletion Dhsp26Dhsp42 strain, [PSI
+]
induction was increased by ,2.1-fold (Figure 4A). Importantly,
immunoblots revealed that neither Hsp104 nor Hsp70 expression
were affected by the sHsp deletion (Figure 4B). Thus, increased
[PSI
+] induction observed in the sHsp deletion strains (Figure 4A)
is likely to be a direct effect of reduced sHsp activity.
Elevated expression of Hsp26 or Hsp42 antagonized [PSI
+]
induction by Sup35 overexpression (Figure 4C). The combination
of Hsp26 and Hsp42 was more effective than either sHsp alone,
and almost as effective as the protein disaggregase Hsp104
(Figure 4C). The expression of Hsp104 and Hsp70 was not altered
by sHsp overexpression (Figure 4D), indicating that these effects
are likely due to sHsp activity. Accordingly, Hsp26 and Hsp42
overexpression prevented the formation of NM-YFP foci, a
reporter of [PSI
+] induction, when NM-YFP was overexpressed
(Figure 4E) [72]. Here too, the combination of Hsp26 and Hsp42
yielded the greatest inhibition (Figure 4E). Importantly, overex-
pression of Hsp26, Hsp42, or both has no effect on the [RNQ
+]
prion [33], which is critical for [PSI
+] induction by Sup35
overexpression [73]. Taken together, these data suggest that
Hsp26 and Hsp42 work together to directly antagonize [PSI
+]
induction.
Hsp26 and Hsp42 Prevent ‘‘Cross-Seeding’’ by Rnq1
Prions
The induction of [PSI
+] by Sup35 overexpression depends on
the presence of another prion [RNQ
+], which is comprised of
infectious Rnq1 amyloid [73]. Rnq1 prions are proposed to
template the initial formation of Sup35 prions in vivo, and this
activity has been reconstituted in vitro [74]. Thus, we tested
whether Hsp26 and Hsp42 inhibited NM fibrillization cross-
seeded by Rnq1 fibers in vitro. Hsp26 or Hsp42 inhibited NM
assembly that was cross-seeded by Rnq1 fibers, whereas a control
protein (BSA) had no effect (Figure 5). The ability of Hsp42 to
inhibit this seeding reaction was unexpected and might suggest
that Rnq1 fibers accelerate events in the lag phase of NM assembly
(Figure 1, steps 1–4), rather than acting as a direct template for
NM fibrillization (Figure 1, step 5) [74]. Hsp26 and Hsp42 might
interact directly with Rnq1 fibers to prevent interactions with NM.
Alternatively, interactions between Hsp26 or Hsp42 and NM
might prevent interactions with Rnq1 that drive cross-seeding.
Importantly, the combination of Hsp26 and Hsp42 was more
potent than either sHsp alone (Figure 5), suggesting that the two
sHsps work together to prevent cross-seeding. Thus, Hsp26 and
Hsp42 antagonize de novo formation of Sup35 prions in vitro and in
vivo.
Fluorescence of NM-N21C-, Q38C-, G96C-, or Y106C-acrylodan (5 mM) after 15 min at 25uC in the absence or presence of BSA (3 mM), Hsp26 (3 mM),
Hsp42 (3 mM), or Hsp26 (1.5 mM) and Hsp42 (1.5 mM). Values represent means6SD (n=3). (C, D) NM (5 mM) was incubated at 25uC with agitation for
10 min at which point (arrow) buffer, Hsp26 (3 mM), or Hsp42 (3 mM) was added. The reaction was then continued at 25uC with agitation to 150 min.
At the indicated times, the amount of A11-reactive species present was determined (C) or the amount of ThT-reactive species was determined (D).
Datasets representative of three replicates are shown. (E) Electron microscopy of NM assembly at 25uC with agitation for 6 h in the absence or
presence of Hsp26 (3 mM), Hsp42 (3 mM), or Hsp26 (1.5 mM) and Hsp42 (1.5 mM). Note the presence of small fibers in the presence of Hsp26 (arrow),
the accumulation of oligomers in the presence of Hsp42 or Hsp26 and Hsp42. Bar, 0.5 mm. (F) NM cysteine variants were either left uncrosslinked or
crosslinked under denaturing conditions with a flexible 11 A ˚ BMB crosslink at position 25 or 31. The indicated NM protein (5 mM) was then assembled
with agitation at 25uC in the absence or presence of BSA (3 mM), Hsp26 (3 mM), Hsp42 (3 mM), or Hsp26 and Hsp42 (1.5 mM of each). Fibrillization was
measured by ThT fluorescence. Values represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g003
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Hsp42
The ability of Hsp26 to inhibit the assembly of BMB-crosslinked
NM (Figure 3F) suggested that Hsp26 might inhibit fibrillization of
NM seeded by preformed NM fibers. Indeed, Hsp26 potently
inhibited (IC50,1.9 mM) NM fibrillization seeded by preformed
NM fibers (5% wt/wt) (Figure 6A,B). Hsp42 also inhibited seeded
assembly (Figure 6A,B). However, Hsp42 was less effective
(IC50.24 mM) and inhibition was only observed at high concen-
trations (Figure 6A,B). In contrast to spontaneous assembly
(Figure 2A,B), the combination of Hsp26 and Hsp42 did not
yield stronger inhibition (Figure 6A,B). Thus, Hsp26 and Hsp42
did not synergize to prevent seeded assembly in vitro (Figure 6A,B),
which is consistent with results obtained with BMB-crosslinked
NM (Figure 3F). Very similar results were obtained using full-
length Sup35 (Figure 6C).
Thermal Activation of Hsp26 Reduces Activity against
Sup35
The strong inhibition of Sup35 prion formation by Hsp26 at
25uC (Figures 2A, 6A) was unexpected because exposure to
elevated temperature is required for Hsp26 to bind unfolded
polypeptides and prevent their aggregation [27,31,32]. Indeed, as
expected, pretreatment of Hsp26 for 10 min at 45uC increased the
ability of Hsp26 to suppress aggregation of glutamate dehydroge-
nase (GDH) (Figure 6D). By contrast, the same pretreatment
reduced the ability of Hsp26 to inhibit spontaneous NM assembly
(Figure 6D). Thus, at elevated temperatures Hsp26 might switch
from inhibiting prion assembly to suppressing aggregation of
denatured substrates. As with spontaneous NM assembly
(Figure 6D), pretreatment of Hsp26 at 45uC reduced its ability
(IC50.24 mM) to inhibit seeded fibrillization (Figure 6A–C). Thus,
conditions that enable Hsp26 to prevent the aggregation of
environmentally denatured proteins reduce the ability of Hsp26 to
antagonize Sup35 prionogenesis. These data suggest that Hsp26
uses a distinct mechanism to antagonize prion formation.
Hsp26 Prevents Intermolecular Prion Contact Formation
Prion recognition elements termed the ‘‘Head’’ (residues ,21–
38) and ‘‘Tail’’ (residues ,91–106) in NM fibers formed at 25uC
make homotypic intermolecular contacts such that fibers are
constructed by ‘‘Head-to-Head’’ and ‘‘Tail-to-Tail’’ contacts
(Figure 1) [40,41]. We asked whether Hsp26 might inhibit either
‘‘Head-to-Head’’ or ‘‘Tail-to-Tail’’ intermolecular contact forma-
tion or both to inhibit seeded fibrillization (Figure 1, step 5). Thus,
we employed six different individual NM single cysteine mutants
labeled with pyrene in either the head (G25C, G31C, or Q38C) or
the tail region (G86C, G96C, or Y106C). Upon intermolecular
contact formation and fibrillization, pyrene molecules form
excimers (excited-state dimers) that produce a strong red shift in
fluorescence [40,41]. Hsp42 only partially inhibited seeded
‘‘Head-to-Head’’ or ‘‘Tail-to-Tail’’ contact formation (Figure 6E).
By contrast, Hsp26 strongly inhibited seeded ‘‘Head-to-Head’’ or
‘‘Tail-to-Tail’’ contact formation, and a 45uC pretreatment
reduced this inhibitory activity (Figure 6E).
Hsp26 Interacts with NM Fibers to Prevent Seeding
To determine whether Hsp26 inhibited seeded assembly by
interacting with NM fibers or monomers or both, we pretreated
NM fibers with Hsp26 or Hsp42. We then recovered the fibers by
centrifugation, washed, and resuspended the material to use as
seed. Hsp26 or Hsp42 did not disassemble NM fibers in this
timeframe and equal amounts of NM were recovered for each
condition. NM fibers pretreated in this way with BSA or Hsp42
could still seed, whereas those pretreated with Hsp26 were unable
to seed (Figure 7A). Very similar results were obtained using
pyrene-labeled NM (Figure 7B). Both Hsp42 and Hsp26 were
recovered in the pellet with NM fibers (Figure 7C) and thus were
present in the seeded assembly reaction. The residual concentra-
tion was estimated to be ,50 nM for Hsp26 and ,20 nM for
Hsp42. These concentrations are not sufficient to cause significant
inhibition of seeded assembly without pretreatment of fibers
(Figure 6A). Thus, Hsp42 binds to NM fibers in a manner that
does not affect seeded assembly. By contrast, Hsp26 binds to NM
Figure 4. Hsp26 and Hsp42 antagonize Sup35 prion formation in vivo. (A) Sup35 was overexpressed for 16 h at 30uC in wild-type, Dhsp26,
Dhsp42,o rDhsp26Dhsp42 [psi
2][ RNQ
+] cells. Cells were plated on 25% YPD and the proportion of [PSI
+] colonies was determined. Compared to wild-
type cells there was significantly more [PSI
+] induction in Dhsp26 cells (*p=0.0264, two-tailed Student’s t test), Dhsp42 cells (**p=0.0059, two-tailed
Student’s t test), or Dhsp26Dhsp42 cells (***p=0.0002, two-tailed Student’s t test). Values represent means6SEM (n=3). (B) Immunoblots
demonstrating that neither Hsp104 nor Hsp70 (3A3 antibody that recognizes yeast Ssa1, Ssa2, Ssa3, and Ssa4 [95]) expression is affected in the
Dhsp26, Dhsp42,o rDhsp26Dhsp42 background. Pgk1 is included as a loading control. (C) Sup35 was overexpressed for 16 h at 30uCi n[ psi
2][ RNQ
+]
cells expressing elevated levels of Hsp26, Hsp42, Hsp26 plus Hsp42, or Hsp104. Cells were plated on 25% YPD and the proportion of [PSI
+] colonies
was determined. Compared to the vector control there was significantly less [PSI
+] induction in cells expressing Hsp26 (*p=0.0253, two-tailed
Student’s t test), Hsp42 (*p=0.028, two-tailed Student’s t test), Hsp26 and Hsp42 (**p=0.0021, two-tailed Student’s t test), or Hsp104 (***p,0.0001,
two-tailed Student’s t test). Values represent means6SEM (n=3). (D) Immunoblots demonstrating that neither Hsp104 nor Hsp70 (3A3 antibody that
recognizes yeast Ssa1, Ssa2, Ssa3, and Ssa4 [95]) expression is affected by elevated expression of Hsp26, Hsp42, or Hsp26 and Hsp42. Pgk1 is included
as a loading control. (E) NM-YFP was transiently overexpressed for 4 h at 30uCi n[ psi
2][ RNQ
+] cells expressing elevated levels of Hsp26, Hsp42, or
Hsp26 and Hsp42. Cells were processed for fluorescence microscopy. The proportion of cells with NM-YFP foci was then determined. (**p,0.01,
***p,0.001, two-tailed Student’s t test). Values represent means6SEM (n=3). Examples of cells with NM-YFP foci (‘‘dots’’ and ‘‘ribbons’’ indicated by
arrows) and cells with diffuse NM-YFP fluorescence are shown on the right.
doi:10.1371/journal.pbio.1001346.g004
Figure 5. Hsp26 and Hsp42 inhibit cross-seeding by Rnq1
fibers. NM (2 mM) was incubated at 25uC for 16 h with or without Rnq1
fibers (10% or 20% wt/wt) without agitation in the absence or presence
of BSA (3 mM), Hsp26 (3 mM), Hsp42 (3 mM), or Hsp26 (1.5 mM) and
Hsp42 (1.5 mM). Fibrillization was measured by ThT fluorescence. Values
represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g005
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assembly.
These results do not exclude that Hsp26 or Hsp42 might also
interact with monomeric NM to inhibit prion formation. Thus, we
pretreated soluble NM-his with Hsp26 or Hsp42 (or BSA). We
then recovered the NM-his using Ni-NTA superflow and used it as
substrate for preformed NM fibers. Hsp26 did not bind NM-his
monomers (Figure 7D), in contrast to the interaction between
Hsp26 and NM fibers (Figure 7C). We detected minimal binding
of Hsp42 to NM-his (Figure 7D), but again this interaction was not
as pronounced as the interaction between Hsp42 and NM fibers
(Figure 7C). The NM-his recovered under each of these conditions
was readily converted to amyloid by NM fibers (Figure 7E). These
data indicate that the direct interaction between Hsp26 and NM
fibers is critical for the inhibition of seeded assembly.
Hsp26 Prevents Seeding by Ex Vivo Sup35 Prions
Next, we tested whether the sHsps could inhibit seeding by ex
vivo Sup35 prions. Several proteins bind Sup35 prions in situ,
most notably Ssa1 [75], which might affect how Hsp42 or Hsp26
influence seeding. Hence, we isolated Sup35 prions from [PSI
+]
cells [75] and used them to seed the assembly of full-length Sup35
Figure 6. Hsp26 inhibits seeded assembly of Sup35 more potently than Hsp42 in a temperature-sensitive manner. (A) NM (5 mM) was
incubated at 25uC for 12 h in the presence of preformed NM fibers (5% wt/wt) plus increasing concentrations of either BSA, Hsp26, Hsp42, or Hsp26
and Hsp42 (0–24 mM). For the mixture of Hsp26 and Hsp42, a 1:1 ratio was employed. Thus, a concentration of 2 mM on the x-axis reflects 1 mM Hsp26
and 1 mM Hsp42. For the Hsp26 alone condition, Hsp26 was pretreated at either 25uCo r4 5 uC for 10 min. Fibrillization was measured by ThT
fluorescence. Values represent means6SD (n=3). (B) NM (5 mM) was incubated at 25uC for 12 h in the presence of preformed NM fibers (5% wt/wt)
plus BSA, Hsp26, or Hsp42 (12 mM). Hsp26 was pretreated at either 25uCo r4 5 uC for 10 min. Fibrillization was measured by determining the amount
of SDS-resistant NM. Values represent means6SD (n=3). (C) Sup35 (5 mM) was incubated at 25uC for 12 h in the presence of preformed Sup35 fibers
(5% wt/wt) plus BSA, Hsp26, or Hsp42 (12 mM). Hsp26 was pretreated at either 25uCo r4 5 uC for 10 min. Fibrillization was measured by ThT
fluorescence. Values represent means6SD (n=3). (D) Chemically denatured GDH or NM (5 mM) was incubated at 25uC for 4 h with agitation in the
presence of Hsp26 (1–10 mM), which had been pretreated at either 25uCo r4 5 uC for 10 min. GDH aggregation was assessed by turbidity and NM
fibrillization by ThT fluorescence. Values represent means6SD (n=3). (E) NM proteins (5 mM) carrying pyrene labels at the indicated single site were
assembled at 25uC for 12 h in the presence of preformed NM fibers (5% wt/wt) plus either Hsp26 or Hsp42 (12 mM). Hsp26 was pretreated at either
25uCo r4 5 uC for 10 min. The ratio of excimer to non-excimer fluorescence (I465 nm/I375 nm) was then determined as a measure of intermolecular
contact formation. Soluble NM serves as a negative control.
doi:10.1371/journal.pbio.1001346.g006
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PLoS Biology | www.plosbiology.org 9 June 2012 | Volume 10 | Issue 6 | e1001346Figure 7. Hsp26 interacts with NM fibers to prevent seeding. (A) NM fibers (5 mM NM monomer) were incubated for 60 min at 25uC without
or with BSA, Hsp26, or Hsp42 (10 mM). NM fibers were then recovered by centrifugation at 16,000 g, gently washed, resuspended in an equal volume
of assembly buffer, and used to seed (2% wt/wt) assembly of NM (5 mM) for 12 h at 25uC. Fibrillization was measured by ThT fluorescence. Values
represent means6SD (n=3). (B) NM fibers were pretreated as in (A) and used to seed (2% wt/wt) assembly of NM proteins (5 mM) carrying pyrene
labels at the indicated single site. The ratio of excimer to non-excimer fluorescence (I465 nm/I375 nm) was then determined as a measure of
intermolecular contact formation. (C) Preassembled NM fibers (5 mM NM monomer) were incubated for 60 min at 25uC without or with Hsp26 or
Hsp42 (10 mM). NM fibers were then recovered by centrifugation at 16,000 g for 30 min. Pellet fractions with or without a wash step were processed
for SDS-PAGE and Coomassie stained. Note the presence of Hsp26 and Hsp42 in the pellet and washed pellet fractions. (D) NM-his (5 mM) was
incubated for 60 min at 25uC without or with Hsp26 or Hsp42 (10 mM). NM-his was recovered with Ni-NTA agarose, washed, and eluted. Eluates were
processed for SDS-PAGE and Coomassie stained. Note the presence of Hsp42 but not Hsp26 in the eluted fractions. (E) NM-his (5 mM) that had been
pretreated with buffer, BSA, Hsp26, or Hsp42 (10 mM) was incubated with NM fibers (5% wt/wt) for 12 h. Fibrillization was measured by ThT
fluorescence. Values represent means6SD (n=3). (F) Ex vivo Sup35 prions (2% wt/wt) were used to seed the assembly of soluble full-length Sup35
(5 mM) for 12 h at 25uC in the absence or presence of BSA, Hsp26, or Hsp42 (10 mM). Fibrillization was measured by ThT fluorescence. Values
represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g007
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prions effectively seeded Sup35 fibrillization and Hsp26 potently
inhibited this process (Figure 7F). Hsp42 also inhibited seeding by
ex vivo Sup35 prions (Figure 7F) but only at high Hsp42
concentrations and was comparable to the inhibition observed
with NM (Figure 6A).
Elevated Expression of Hsp26 and Hsp42 Effectively
Cures [PSI
+]
The inhibition of seeded assembly by Hsp26 (Figures 6A–C,E,
7F) suggested that Hsp26 might interfere with [PSI
+] propagation
in vivo. Indeed, elevated expression of Hsp26 effectively cured
[PSI
+], whereas [PSI
+] curing was not detected in the vector
control (Figure 8). Surprisingly, even though Hsp42 did not
effectively inhibit seeded assembly (Figures 6A–C,E, 7F), elevated
expression of Hsp42 also effectively cured [PSI
+] (Figure 8).
Moreover, elevated expression of both Hsp26 and Hsp42 cured
[PSI
+] just as effectively as overexpression of Hsp104 (Figure 8),
which is a potent method of [PSI
+] curing [76]. Thus, Hsp26 and
Hsp42 work together to eliminate Sup35 prions in vivo.
Hsp42 Synergizes with Hsp70 to Antagonize Sup35
Prionogenesis
The magnitude of the [PSI
+] curing effect by Hsp42 overex-
pression (Figure 8) was unexpected because it is much less effective
in inhibiting seeded assembly than Hsp26 (Figures 6A–C,E, 7F).
We reasoned that Hsp42 might collaborate with other chaperones
to antagonize seeded Sup35 assembly. Ssa1, an Hsp70 chaperone,
can collaborate with Hsp40 partners (Sis1 or Ydj1) to inhibit
seeded fibrillization of NM [55]. This inhibition is due to an
interaction between the fiber and Hsp70 and Hsp40 because
neither Ssa1:Ydj1 nor Ssa1:Sis1 interact with NM monomers
directly [55]. We tested whether the seeding activity of NM fibers
that had been pretreated with Hsp42 were more sensitive to
inhibition by increasing concentrations of Ssa1:Sis1 or Ssa1:Ydj1.
We first confirmed that adding Ssa1, Ydj1, or Sis1 alone had no
effect on seeding by NM fibers or seeding by NM fibers pretreated
with Hsp42 (Figure 9A–C). Next, we titrated Ssa1:Sis1 or
Ssa1:Ydj1 into seeded assembly while maintaining the Ssa1:Hsp40
ratio at 1:1. As expected, both Ssa1:Sis1 and Ssa1:Ydj1 inhibited
seeded assembly of buffer-treated NM fibers with an IC50 of
,1.1 mM and ,1.6 mM, respectively (Figure 9D,E). However,
Hsp42-treated NM fibers were more susceptible to inhibition by
Ssa1:Sis1 and Ssa1:Ydj1 (Figure 9D,E). The IC50 was reduced
about 5-fold to ,0.21 mM for Ssa1:Sis1 and about 3-fold to
,0.49 mM for Ssa1:Ydj1. These marked decreases in IC50 suggest
that Hsp42 binds NM fibers and promotes interactions between
the prion and Ssa1:Sis1 or Ssa1:Ydj1 that preclude seeded
assembly. Thus, Hsp42 may direct Hsp70 and Hsp40 to fiber
ends to prevent assembly.
These results were corroborated in vivo. Two titers of synthetic
NM prions were transformed into [psi
2] cells overexpressing the
indicated combination of Hsp26, Hsp42, Ydj1, or Sis1 (Figure 9F).
Importantly, [PSI
+] induction by NM fibers was reduced by the
overexpression of either sHsp or either Hsp40 especially at lower
prion titers (Figure 9F). The greatest inhibition was observed when
Hsp26 and Hsp42 were combined (Figure 9F). At higher prion
titers, the combination of sHsp and Hsp40 was more potent than
the sHsp alone (Figure 9F). Specifically, the combination of Hsp26
plus Ydj1 was more effective in preventing infection than Hsp26
alone (two-tailed Student’s t test; p=0.005), as was Hsp26 plus Sis1
(two tailed Student’s t test; p=0.0012). Similarly, the combination
of Hsp42 plus Ydj1 was more effective in preventing infection than
Hsp42 alone (two-tailed Student’s t test; p=0.006), as was Hsp42
plus Sis1 (two-tailed Student’s t test; p=0.0025). These data
suggest that Hsp42 can collaborate with Hsp70 and Hsp40 to
prevent seeding by NM prions in vivo. They also suggest that
Hsp26 can prevent seeding by preformed NM prions in vivo.
Hsp26 and Hsp42 Binding Destabilizes NM Fibers
Does Hsp26 or Hsp42 binding alter prion structure? Although
Hsp26 and Hsp42 did not disassemble NM fibers after a brief
incubation, they both induced a slight decrease in the thermal
stability of NM fibers in 1.6% SDS. The melting temperature was
slightly reduced from 7861uCt o7 1 61uC for Hsp26 and to
7261uC for Hsp42 (Figure 10A), whereas Ssa1 plus Sis1 had no
effect (Figure 10A). Thus, sHsp binding to NM fibers might
weaken or subtly alter the intermolecular contacts between NM
protomers, and shift the monomer-fiber equilibrium in favor of
dissociation. In this way, sHsps might render amyloid forms more
susceptible to dissolution by protein disaggregases.
To monitor intermolecular contacts directly, we independently
assembled 17 individual single cysteine NM mutants labeled with
pyrene [40,41]. We then determined how Hsp26 and Hsp42
binding affected excimer fluorescence at these positions. Excimer
fluorescence detects intermolecular contact integrity and the
proximity of residues within different protomers of the assembled
prion [40,41]. Ssa1 and Sis1 had no effect on excimer fluorescence
(Figure 10B), whereas Hsp26 and Hsp42 caused subtle but
significant alterations in excimer fluorescence at almost every
position tested (Figure 10B). Excimer fluorescence in the Head
(amino acids 21–38) and Tail (amino acids 86–106) regions was
slightly reduced (Figure 10B). The most drastic alteration was
observed in the extreme N-terminal positions 2 and 7, where
excimer fluorescence was reduced ,2-fold (Figure 10B). Thus,
Hsp26 or Hsp42 binding alters prion architecture in a way that
weakens intermolecular contacts and forces residues that are N-
terminal to the Head contact (amino acids 21–38) further apart.
Figure 8. Elevated expression of Hsp26 and Hsp42 effectively
cures [PSI
+]. Hsp26, Hsp42, Hsp26 plus Hsp42, or Hsp104 were
overexpressed in [PSI
+] cells in liquid for 6 h at 30uC. Empty vector
served as the control. Cells were plated on 25% YPD and the proportion
of [PSI
+] colonies was determined. Compared to the vector control there
was significantly more [PSI
+] curing in cells expressing Hsp26
(**p=0.00249, two-tailed Student’s t test), Hsp42 (*p=0.0387, two-
tailed Student’s t test), Hsp26 and Hsp42 (***p=0.000187, two-tailed
Student’s t test), or Hsp104 (**p=0.00148, two-tailed Student’s t test).
Values represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g008
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dissolution by prion disaggregases such as Hsp104.
Hsp26 and Hsp42 Promote Rapid Disassembly of Sup35
Prions by Hsp104
The destabilization of Sup35 prions by Hsp26 or Hsp42 binding
could be exploited by Hsp104 to rapidly disaggregate prions.
Thus, we assembled NM fibers and incubated them with
increasing concentrations of Hsp104 in the presence or absence
of Hsp26 or Hsp42. In the absence of other components Hsp104
effectively disassembled NM fibers, with an EC50 of ,0.15 mM
(Figure 11A). Remarkably, Hsp42 enabled Hsp104 to disassemble
NM fibers at concentrations where it would usually be inactive
(0.01–0.1 mM; Figure 11A). Hsp42 reduced the Hsp104 EC50 to
,0.075 mM. By contrast, Hsp26 inhibited Hsp104 activity
(Figure 11A). Addition of Ssa1:Sis1 had little effect on Hsp104
activity in the absence of sHsps (the Hsp104 EC50 was ,0.14 mM;
Figure 11B). However, Ssa1:Sis1 enhanced Hsp104 activity in the
presence of Hsp42 and reduced the Hsp104 EC50 to ,0.05 mM
(Figure 11B). Ssa1:Sis1 relieved the inhibition of Hsp104 by Hsp26
and potentiated Hsp104 remodeling activity, reducing the EC50 to
,0.06 mM. We confirmed that prions had been protected or
Figure 9. Hsp42 synergizes with Ssa1:Sis1 and Ssa1:Ydj1 to inhibit seeded assembly of NM. (A–E) NM fibers (5 mM NM monomer) were
incubated for 60 min at 25uC with buffer or Hsp42 (10 mM). NM fibers were then recovered by centrifugation at 16,000 g, gently washed,
resuspended in an equal volume of assembly buffer, and used to seed (2% wt/wt) assembly of NM (5 mM) for 12 h at 25uC in the presence of ATP
(5 mM) and increasing concentrations of Ssa1 (A), Sis1 (B), Ydj1 (C), Ssa1:Sis1 (D), or Ssa1:Ydj1 (E). Fibrillization was monitored by ThT fluorescence.
Values represent means6SD (n=3). (F) NM fibers (5 mM or 1.25 mM) were sonicated and transformed into [psi
2] cells overexpressing the indicated
combination of Hsp26, Hsp42, Sis1, and Ydj1. The proportion of [PSI
+] colonies was then determined. Values represent means6SD (n=5).
doi:10.1371/journal.pbio.1001346.g009
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2] cells (Figure 11C).
These data suggest that sHsps enhance the ability of Hsp104 to
eliminate Sup35 prions.
Next, we tested whether overexpression of Hsp26 or Hsp42
increased [PSI
+] curing by elevated Hsp104 concentrations.
Consistent with our in vitro observations, Hsp26 and Hsp42
synergized with Hsp104 to promote [PSI
+] curing (Figure 11D).
These data reinforce our in vitro observations that sHsps
potentiate Hsp104 activity against Sup35 prions.
Hsp26 and Hsp42 Promote Rapid Disassembly of Diverse
Amyloids by Hsp104
Next, we tested whether the sHsps potentiated Hsp104 activity
against a-syn amyloid, which is connected to Parkinson’s disease
[1,77,78], and polyglutamine amyloid, which is connected to
Huntington’s disease [1,79]. a-Syn and polyglutamine (Q62) fibers
were assembled and preincubated with either Hsp26 or Hsp42.
The indicated combination of Hsp104, Ssa1, and Sis1 was then
added. sHsps promoted rapid disassembly of a-syn and polyglu-
tamine fibers by Hsp104 (Figure 11E). Indeed, preincubation with
Hsp26 enabled Hsp104 to catalyze more a-syn fiber disassembly
(two-tailed Student’s t test; p=0.0031) and more Q62 fiber
disassembly (two-tailed Student’s t test; p=0.0037) than Hsp104
alone. For these amyloid substrates, Hsp26 alone did not
antagonize Hsp104 activity (Figure 11E). Preincubation of fibers
with Hsp42 also enabled Hsp104 to catalyze more a-syn fiber
disassembly (two-tailed Student’s t test; p=0.0209) and more Q62
fiber disassembly (two-tailed Student’s t test; p=0.0019) than
Hsp104 alone. Optimal disaggregation was achieved with sHsp
plus Hsp104, Ssa1, and Sis1 (Figure 11E). Thus, sHsps potentiate
Hsp104 activity against disease-associated amyloid.
Hsp42 Is an Amyloid-Specific Adaptor for Hsp104
Next, we asked whether Hsp42 could function like Hsp26 to
promote the disaggregation of disordered aggregates by Hsp104
[33]. In contrast to Hsp26, Hsp42 did not promote the
disaggregation of heat-denatured luciferase aggregates by
Hsp104, Hsp70, and Hsp40 (Figure 11F). These data help explain
why Hsp26, but not Hsp42, assists Hsp104 in promoting luciferase
disaggregation and thermotolerance in vivo [33]. Thus, Hsp42
selectively promotes the disassembly of amyloid conformers by
Hsp104, whereas Hsp26 promotes Hsp104-catalyzed disaggrega-
tion of both amyloid and non-amyloid aggregates.
Hsp110, Hsp70, and Hsp40 Promote Slow Disassembly of
NM Fibers
Metazoa lack an Hsp104 orthologue and how amyloid might be
disaggregated in animal systems remains unknown [60]. In
general, monomers at fiber ends are more likely to be susceptible
to disaggregation because they are only restrained by one
intermolecular contact (e.g., Head or Tail, Figure 1). Indeed,
fiber ends are dynamic and monomers slowly dissociate within a
biologically relevant timeframe (days) and rapidly reassociate in a
process termed molecular recycling (Figure 12A) [62–64,67,68].
Dissociation is the rate-limiting step in recycling and reassociation
is rapid. A homogeneous population of fibers formed by a SH3
domain with an average length of 100 nm, recycle ,50% of
monomers within 2 to 20 d [62]. Thus, agents that accelerate
monomer dissociation or prevent monomer reassociation or both
could drive fiber depolymerization on a timescale similar to that of
molecular recycling. For example, Hsp26 and Hsp70:Hsp40 pairs
(e.g., Ssa1:Sis1) prevent seeded assembly (Figures 6A–C, 9D, 9E)
and might inhibit monomer reassociation events (Figure 12A). We
were particularly interested in Hsp110 in this context. Hsp110 can
synergize with Hsp70 and Hsp40 to extract and refold proteins
from denatured aggregates [61]. Thus, the combination of
Hsp110, Hsp70, and Hsp40 might even accelerate dissociation
of monomers from fiber ends.
We assembled and sonicated NM fibers to generate a uniform
population of short fibers [43]. NM fibers were stable for 28 d
alone (black filled squares, Figure 12B,C) or in the presence of
molecular chaperones that alone do not affect seeded assembly,
including Hsp42 (blue filled triangles, Figure 12B,C), Sis1 (black
open squares, Figure 12B,C), Ydj1 (red open circles, Figure 12B,C),
Ssa1 (black open triangles, Figure 12B,C), or Sse1 (blue filled
squares, Figure 12B,C). In remarkable contrast, Hsp26 (red filled
Figure 10. Hsp26 or Hsp42 binding destabilizes NM fibers. (A) NM fibers (5 mM NM monomer) were incubated for 60 min at 25uC without or
with Hsp26 (10 mM), Hsp42 (10 mM), or Ssa1:Sis1 (10 mM of each) in the presence of ATP (5 mM). The stability of the various NM fibers was then
determined by SDS–PAGE and quantitative immunoblot. The amount of SDS-soluble NM, which reflects susceptibility of NM fibers to thermal
solubilization, was plotted against temperature and fitted to a sigmoidal function. Values represent means6SD (n=3). (B) NM proteins (5 mM)
carrying pyrene labels at the indicated single site were assembled at 25uC with agitation for 12 h. Assembled NM fibers (5 mM NM monomer) were
then incubated for 60 min at 25uC without or with buffer, Hsp26, Hsp42, or Ssa1:Sis1 (10 mM) in the presence of ATP (5 mM). The ratio of excimer to
non-excimer fluorescence (I465 nm/I375 nm) was then determined.
doi:10.1371/journal.pbio.1001346.g010
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Figure 12B,C), and Ssa1:Ydj1 (black open circles, Figure 12B),
which inhibit seeded assembly (6A, 6B, 9D, 9E), slowly disassem-
bled preformed NM fibers over a time period of 28 d
(Figure 12B,C). Consistent with their efficacy to inhibit seeded
assembly, Ssa1:Sis1 (blue open triangles, Figure 12B,C) was more
effective than Ssa1:Ydj1 (black open circles, Figure 12B,C) or
Hsp26 (red filled circles, Figure 12B,C). Notably, the combination
of Sse1 (Hsp110), Ssa1 and Sis1 (green filled squares,
Figure 12B,C), or Sse1, Ssa1, and Ydj1 (cyan filled triangles,
Figure 12B,C) yielded more rapid disassembly, whereas Sse1
combined with Ssa1 (red filled squares, Figure 12B,C), Sis1 (black
filled circles, Figure 12B,C), or Ydj1 (red filled triangles,
Figure 12B,C) had no effect. Electron microscopy (Figure 12D)
and prion transformation (Figure 12E) confirmed that prions had
been eliminated by Sse1:Ssa1:Sis1, Sse1:Ssa1:Ydj1, Ssa1:Sis1,
Ssa1:Ydj1, and Hsp26, but not by Sse1:Ssa1, Sse1:Sis1, Sse1:Ydj1,
Sse1, Ssa1, Ydj1, Sis1, or Hsp42.
Disassembly was contingent on the number of fiber ends, as
unsonicated fibers were more refractory to disassembly
(Figure 12F). Indeed, we confirmed that disassembly entailed
depolymerization from fiber ends using ‘‘capped’’ fibers. Thus,
NM fibers comprised of untagged NM were resuspended in buffer
containing high concentrations of C-terminally his-tagged NM.
This procedure allowed NM fibers to be rapidly elongated creating
NM fibers with NM-his ‘‘caps’’ (Figure 13A). We established
conditions where ,50% of the total NM in fibers was his-tagged
(Figure 13A). If NM fibers with NM-his ‘‘caps’’ were treated for
extended periods with Sse1:Ssa1:Sis1, Sse1:Ssa1:Ydj1, Ssa1:Sis1,
Ssa1:Ydj1, or Hsp26, then only NM-his was released into the
soluble fraction (Figure 13B,C). Conversely, if NM-his fibers were
capped with untagged NM (Figure 13A), then only untagged NM
was released into the soluble fraction (Figure 13D,E). When
capped fibers were sonicated prior to incubation to randomize the
form of NM at fiber ends, approximately equal amounts of NM
and NM-his were released (Figure 13F,G). Taken together, these
data suggest that Sse1:Ssa1:Sis1, Sse1:Ssa1:Ydj1, Ssa1:Sis1,
Ssa1:Ydj1, and Hsp26 slowly depolymerize NM fibers from their
ends. The most effective depolymerization is promoted by the
combination of Hsp110, Hsp70, and Hsp40.
sHsps Can Promote Depolymerization of NM Fibers by
Hsp110, Hsp70, and Hsp40
Hsp110, Hsp70, and Hsp40 might exploit the destabilization of
amyloid by sHsp binding (Figure 10A,B) to promote amyloid
depolymerization. Thus, NM fibers were pretreated with Hsp26 or
Hsp42 prior to addition of Sse1:Ssa1:Sis1 or Sse1:Ssa1:Ydj1.
Pretreatment with Hsp26 or Hsp42, which subtly alters NM fiber
structure and stability (Figure 10A,B), facilitated more rapid
depolymerization by Sse1:Ssa1:Sis1 (Figure 13H) or Sse1:S-
sa1:Ydj1 (Figure 13I). For Sse1:Ssa1:Sis1, the D1/2 (the 50%
disassembly time) was reduced from ,12.8 d to ,7.4 d by Hsp26
and to ,7.7 d by Hsp42. For Sse1:Ssa1:Ydj1, D1/2 was reduced
from ,16.1 d to ,10.5 d by Hsp26 and ,10.9 d by Hsp42.
Thus, sHsps render amyloid forms more susceptible to depoly-
merization by the Hsp110, Hsp70, and Hsp40 disaggregase
machinery.
Human HspB5 Promotes Depolymerization of a-Syn
Fibers by Human Hsp110, Hsp70, and Hsp40
Our newly discovered amyloid-depolymerase activity was not
restricted to yeast chaperones and yeast prions. Indeed, human
Hsp70 (Hsc70) and Hsp40 (Hdj1) slowly disassemble preformed a-
syn fibers (Figure 14A,B). This activity was stimulated by addition
of human Hsp110 (Apg-2) or the human sHsp, HspB5
(Figure 14A,B). HspB5 potentiated a-syn fiber disassembly by
Apg-2, Hsc70 and Hdj1 (Figure 14A,B). Indeed, HspB5 reduced
the D1/2 to ,14 d for Apg-2, Hsc70, and Hdj1. We confirmed
that the combination of Apg-2, Hsc70, Hdj1, and HspB5
depolymerized fibers from their ends by employing a-syn fibers
capped with his-a-syn. Thus, during the initial disassembly phase
of unsonicated fibers, Apg-2, Hsc70, Hdj1, and HspB5 liberated
only his-a-syn into the soluble fraction (Figure 14C), which
indicates that disassembly proceeds via depolymerization. These
data suggest that the human proteostasis network, like its yeast
counterpart, is equipped with an amyloid-depolymerase modality.
Although depolymerization is relatively slow, it occurs on a
biologically relevant timescale, especially considering the lifespan
of neurons in the human brain.
Could Hsp104 interface with the human sHsp, HspB5, and the
Hsp110, Hsp70, and Hsp40 disaggregase machinery? Remark-
ably, the combination of Apg-2, Hsc70, Hdj1, and HspB5 enabled
even more effective and rapid disaggregation of a-syn fibers by
Hsp104 than with just Apg-2, Hsc70, and Hdj1 (Figure 14D) [61].
The ability of Hsp104 to interface effectively with the human
disaggregase machinery and enable effective clearance of a-syn
amyloid suggests that Hsp104 might be developed further to target
pathological a-syn conformers. Collectively, our studies suggest
that sHsps are ubiquitous potentiators of amyloid disassembly by
the proteostasis network.
Discussion
We have established that the sHsps from yeast, Hsp26 and
Hsp42, exert tight control over the formation of beneficial Sup35
prions. Both sHsps exerted a strong and direct inhibitory effect on
Figure 11. Hsp26 or Hsp42 promotes rapid amyloid disassembly by Hsp104. (A, B) NM fibers (2.5 mM monomer) were pretreated for 1 h at
25uC with either buffer, Hsp26 (10 mM), or Hsp42 (10 mM). Hsp104 (0–0.5 mM) was then added in the absence (A) or presence (B) of Ssa1:Sis1 (2.5 mM
each) and reactions were incubated for a further 60 min at 25uC. Fiber integrity was then assessed by ThT fluorescence. Values represent means6SD
(n=3). (C) NM fibers (2.5 mM monomer) were pretreated for 1 h at 25uC with either buffer, Hsp26 (10 mM), or Hsp42 (10 mM). Hsp104 (0.15 mM) was
then added in the absence or presence of Ssa1:Sis1 (2.5 mM each) and reactions were incubated for a further 60 min at 25uC. Reaction products were
concentrated, sonicated, and transformed into [psi
2] cells. The proportion of [PSI
+] colonies was then determined. Values represent means6SD
(n=3). (D) Hsp104, Hsp26, Hsp42, or the indicated combination were overexpressed in [PSI
+] cells in liquid for 6 h at 30uC. Cells were plated on 25%
YPD and the proportion of [psi
2] colonies was determined. Values represent means6SD (n=3). (E) a-Syn fibers (0.5 mM monomer, green bars) or Q62
fibers (1 mM monomer, black bars) were pretreated for 1 h at 25uC with either buffer, Hsp26 (10 mM), or Hsp42 (10 mM). Hsp104 (10 mM) was then
added in the absence or presence of Ssa1:Sis1 (10 mM each) and reactions were incubated for a further 60 min at 25uC (for Q62) or 37uC (for a-syn).
Fiber integrity was then assessed by ThT fluorescence. Values represent means6SD (n=3). (F) Luciferase (0.1 mM) was aggregated for 15 min at 45uC
in the presence of the indicated concentration of sHsp (Hsp26 or Hsp42). Protein aggregates were diluted 20-fold into chaperone mixtures containing
Hsp104 (1 mM), Ssa1 (1 mM), and Ydj1 (1 mM) plus ATP (5 mM) and incubated for 90 min at 25uC. Native luciferase activity at the same concentration
was set to 100%. Note that Hsp26 stimulates luciferase reactivation, whereas Hsp42 does not. Note that Hsp104 alone or Ssa1 and Ydj1 alone do not
promote luciferase reactivation under these conditions [33].
doi:10.1371/journal.pbio.1001346.g011
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PLoS Biology | www.plosbiology.org 15 June 2012 | Volume 10 | Issue 6 | e1001346Figure 12. Gradual disassembly of Sup35 prions by Hsp26 or Hsp110, Hsp70, and Hsp40. (A) Molecular recycling model. Monomers at the
fiber ends are constantly dissociating and reassociating. An example monomer is shown in black. koff is the rate constant for the dissociation of a
monomer from a fiber end and kon is the rate constant for the association of a monomer with a fiber end. kon is several orders of magnitude greater
than koff. (B–E) NM fibers (2.5 mM) were sonicated and then incubated at 25uC for 0–28 d in the absence or presence of Hsp26 (5 mM), Hsp42 (5 mM),
Sis1 (5 mM), Ydj1 (5 mM), Ssa1 (5 mM), Sse1 (5 mM), Sse1:Ssa1, Sse1:Sis1, Sse1:Ydj1, Ssa1:Sis1 (2.5 mM each), Ssa1:Ydj1 (2.5 mM each), Sse1:Ssa1:Sis1
(1.67 mM each), or Sse1:Ssa1:Ydj1 (1.67 mM each). At the indicated times, reactions were centrifuged at 436,000 g for 30 min. The amount of SDS-
soluble NM in the supernatant was then determined by quantitative immunoblot (B). Values represent means6SD (n=3). Alternatively, at the
indicated times, fiber integrity was assessed by ThT fluorescence (C). Values represent means6SD (n=3). After 28 d, fiber integrity was assessed by
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PLoS Biology | www.plosbiology.org 16 June 2012 | Volume 10 | Issue 6 | e1001346Sup35 prion formation at substoichiometric concentrations. These
results were surprising because sHsps commonly bind 1 substrate
per ,2–3 sHsp monomers [24,27]. Thus, the strong inhibitory
effect at substoichiometric concentrations indicates that the sHsps
might inhibit a rare or transient NM conformer that is critical for
prion formation. Surprisingly, our results suggested that this
conformer was different for each sHsp. Hsp42 targeted molten
Sup35 oligomers, whereas Hsp26 targeted the self-templating ends
of newly assembled prions (Figure 1).
Although little was known about Hsp42, it had been suggested
to work by a mechanism similar to Hsp26 to inhibit protein
aggregation [28]. Surprisingly, however, Hsp42 inhibited sponta-
neous Sup35 prionogenesis by a distinct mechanism to Hsp26.
Hsp42 specifically antagonized events in the lag phase of prion
formation. Hsp42 prevented and reversed the maturation of
Sup35 oligomers into prion-nucleating species (Figure 1, steps 2
and 3). By contrast, Hsp26 bound to newly formed prions and
inhibited their seeding activity (Figure 1, step 5). These two
activities synergized to inhibit de novo Sup35 prionogenesis in vitro
and in vivo. To the best of our knowledge, this is the first example
of two distinct sHsps working together in a synergistic manner to
prevent prion formation.
The mechanistic differences between Hsp26 and Hsp42 are
likely conferred by their divergent N-terminal domains. Hsp42 has
an extended N-terminal domain [80], which displays no homology
to other sHsps. The extended N-terminal domain of Hsp42 might
enable insertion into molten Sup35 oligomers in a way that
precludes prion formation.
Hsp26 chaperone activity is usually activated at heat shock
temperatures [27,29,31,32]. Unexpectedly, we found that pre-
treatment of Hsp26 at high temperature reduced its ability to
inhibit Sup35 prionogenesis, while simultaneously enhancing its
ability to prevent aggregation of a chemically denatured substrate.
Our result thus reveals a fundamental difference in how Hsp26
antagonizes the aggregation of a denatured protein (GDH) and a
yeast prion (Sup35). Hsp26 conformations that are ineffective
against heat-denatured substrates are effective against Sup35
prions and vice versa. This difference might reflect distinct driving
forces of GDH and Sup35 aggregation. GDH aggregation likely
involves inappropriately exposed hydrophobic surfaces, whereas
NM fibrillization likely involves polar interactions or backbone
interactions or both because polar residues outweigh hydrophobic
residues by ,16 to 1. At physiological temperatures, Hsp26 may
be primed to inhibit prion formation, but at elevated tempera-
tures, Hsp26 loses this ability and switches to inhibiting the
aggregation of heat-denatured proteins. This switch in Hsp26
activity likely contributes to the increased levels of [PSI
+] induction
at elevated temperatures [11].
Both Hsp26 and Hsp42 bind to preformed Sup35 fibers, but
only Hsp26 binding inhibited seeding activity. However, Hsp42
increased the ability of Hsp70 and Hsp40 (Ssa1:Sis1 or Ssa1:Ydj1)
to inhibit seeded assembly, potentially by recruiting Hsp70 to fiber
ends. These data help explain why overexpression of Hsp26 or
Hsp42 cures cells of [PSI
+].
Unexpectedly, Hsp26 or Hsp42 binding destabilized Sup35
prions. Hsp26 and Hsp42 binding reduced excimer fluorescence at
intermolecular contact regions. The most marked effect was at
residues N-terminal to the Head region, which appeared to be
forced further apart in adjacent protomers by Hsp26 or Hsp42
binding. These data suggest that Hsp26 or Hsp42 harness binding
energy to alter prion architecture. Notably, these sHsp-induced
alterations facilitated the disaggregation of Sup35 prions by
Hsp104.
Pretreatment of Sup35 prions with Hsp42 rendered them more
susceptible to rapid disassembly by Hsp104. Curiously, Hsp26
alone inhibited Hsp104. However, Ssa1 and Sis1 alleviated this
inhibition and promoted more effective prion disassembly. These
findings might suggest that the mechanism of Sup35 prion
disassembly by Hsp104 is different in the presence of Hsp26
versus Hsp42. Further experiments are needed to explore this
possibility. Importantly, Hsp26 and Hsp42 promoted elimination
of Sup35 prions by Hsp104 in vivo, as overexpression of Hsp26 or
Hsp42 increased [PSI
+] curing by elevated Hsp104 concentration.
Hsp26 and Hsp42 also promoted rapid Hsp104-catalyzed
disassembly of a-syn fibers that are connected with PD. We
further demonstrated that Hsp104 directly disassembles polyglu-
tamine fibers that are connected with HD. Hsp26 or Hsp42
boosted this activity and disaggregation was maximal in the
presence of Hsp104, an sHsp, Ssa1, and Sis1.
We have established an important dichotomy between how
Hsp26 and Hsp42 collaborate with Hsp104. Hsp26 promotes the
disaggregation of both amyloid and non-amyloid substrates by
Hsp104 in the presence of Hsp70 and Hsp40. By contrast, Hsp42
selectively promotes the disassembly of amyloid substrates by
Hsp104. Thus, Hsp42 is an amyloid-specific adaptor for Hsp104.
In yeast, Hsp42 appears to preferentially localize to peripheral
inclusions [34] that might harbor amyloid conformers that can be
solubilized by Hsp104 [53,56,81,82].
We have shown that in the absence of Hsp104, the Hsp110,
Hsp70, and Hsp40 disaggregase system [61] can slowly depoly-
merize amyloid fibers. Depolymerization was a slow process that
required many days to complete and appeared to occur on a
timescale similar to molecular recycling within amyloid fibers
[62,67]. Thus, the proteostasis network might exploit this process
to slowly eradicate amyloid by either accelerating monomer
dissociation from fiber ends (i.e., increasing koff, Figure 12A) or
inhibiting monomer reassociation with fiber ends (i.e., decreasing
kon, Figure 12A) or both. Consistent with the possibility of
inhibiting monomer reassociation (decreasing kon, Figure 12A),
agents that inhibit seeded polymerization of Sup35 prions (e.g.,
Hsp26 or Ssa1:Sis1) slowly depolymerized them over the course of
many days. The relatively low number of Hsp26 monomers per
molecule of substrate required for Hsp26 disaggregation activity
might indicate that Hsp26 acts selectively at fiber ends. The
combination of Sse1, Ssa1, and Sis1 yielded the most effective
depolymerization. Given the capability of this disaggregase system
to extract and refold proteins from large denatured aggregates
[61], we suggest that Hsp110, Hsp70, and Hsp40 might also
accelerate monomer dissociation events (increasing koff,
electron microscopy (D). Sonicated NM fibers at the start of the reaction (t=0) are shown at the top left for comparison. Note the absence of fibers in
the presence of Sse1:Ssa1:Sis1, Sse1:Ssa1:Ydj1, and Ssa1:Sis1 and a collection of shorter forms in the presence of Hsp26 or Ssa1:Ydj1. Bar, 0.5 mm (D).
Alternatively, at the indicated times, reaction products were concentrated and transformed into [psi
2] cells. The proportion of [PSI
+] colonies was
then determined (E). Values represent means6SD (n=3). (F) NM fibers (2.5 mM) were not sonicated and then incubated at 25uC for 0–28 d in the
absence or presence of Hsp26 (5 mM), Ssa1:Sis1 (2.5 mM each), Ssa1:Ydj1 (2.5 mM each), Sse1:Ssa1:Ydj1 (1.67 mM each), or Sse1:Ssa1:Sis1 (1.67 mM
each). At the indicated times, reactions were centrifuged at 436,000 g for 30 min. The amount of SDS-soluble NM in the supernatant was then
determined by quantitative immunoblot. Values represent means6SD (n=3). Note the extent of disassembly is not as extensive as when NM fibers
are sonicated as in (B).
doi:10.1371/journal.pbio.1001346.g012
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or Hsp42 accelerated prion depolymerization by Hsp110, Hsp70,
and Hsp40.
Intriguingly, this activity is not confined to yeast but is
conserved to humans. Thus, the human sHsp, HspB5, acceler-
ated the depolymerization of a-syn amyloid (which is connected
with PD) by human Hsp110 (Apg-2), Hsp70 (Hsc70), and Hsp40
(Hdj1). Collectively, these data suggest that in metazoa, which
lack an Hsp104 homologue, Hsp110, Hsp70, and Hsp40 can
slowly eliminate amyloid forms by specifically exploiting the
molecular recycling process (Figure 12A). Although amyloid
depolymerization is slow and requires many days to complete, it
occurs on a biologically relevant timescale, especially considering
the lifespan of humans. Indeed, a massive therapeutic advance
will likely come with the ability to stimulate the proteostasis
network to dissolve a-syn fibers in a few days in Parkinson’s
patients. Our data provide proof of principle that this may indeed
be possible and that pure, individual components can drive this
process. Although released monomers could have a chance to
reassemble into toxic oligomers, we suspect that components of
the proteostasis network would prevent toxic oligomer formation.
Shutting down expression of an amyloidogenic protein enables
mammalian cells to slowly clear protein aggregates [83,84]. Our
findings suggest that sHsps and the Hsp110, Hsp70, and Hsp40
disaggregase system might play a crucial role in this clearance.
Moreover, they suggest that potential RNA interference therapies
to deplete the aggregating protein should be combined with
targeted upregulation of sHsps and the Hsp110, Hsp70, and
Hsp40 disaggregase system to promote clearance of existing
aberrant conformers.
Another way to accelerate the disaggregation of a-syn fibers is to
introduce Hsp104 [54,61]. Indeed, the combination of Hsp104
with Apg-2, Hsc70, Hdj1, and HspB5 disaggregated a-syn fibers
most effectively and rapidly. Importantly, Hsp104 expression
counteracts neurodegeneration associated with a-syn misfolding
and polyglutamine misfolding in rodents [54,59,85,86]. Thus, our
findings suggest that boosting sHsp levels or activity might provide
a powerful strategy to facilitate clearance of deleterious amyloid by
either the endogenous human Hsp110, Hsp70, and Hsp40
disaggregase machinery [61] or by Hsp104 in targeted therapeutic
strategies [54,59,85–87].
Materials and Methods
Proteins
Hsp26 [27], Hsp42 [28], Ssa1, Sis1, Ydj1, NM [48], NM-his
[51], Sup35 [49], Hsp104 [88], Apg-2 [89], Sse1 [90], Rnq1 [74],
polyglutamine (GST-Q62) [91], and a-syn [92] were purified as
described. Hsc70 and Hdj1 were from Enzo Life Sciences. HspB5
was from ProSpec. BSA and firefly luciferase were from Sigma and
GDH was from Roche. Single cysteine NM mutants were labeled
with pyrene-maleimide or acrylodan (Invitrogen) or crosslinked with
BMB (Pierce) under denaturing conditions asdescribed [40]. Throu-
ghout the manuscript, protein concentrations refer to the monomer,
with the exception of Hsp104, where it refers to the hexamer.
Plasmids for Chaperone Overexpression in Yeast
The plasmids used for overexpression of Hsp26, Hsp42,
Hsp104, Ydj1, Sis1, Sup35, and NM-YFP were as described
[33,41,90,93].
GDH Aggregation
The aggregation of denatured GDH was monitored by turbidity
at 395 nm [31]. In some experiments, Hsp26 was thermally
activated by incubation at 45uC for 10 min prior to addition to
aggregation assays.
Fiber Assembly
NM (5 mM) fibrillization was conducted in assembly buffer
(AB) (40 mM HEPES-KOH, pH 7.4, 150 mM KCl, 20 mM
MgCl2, 1 mM DTT). For Sup35 (5 mM) fibrillization, AB was
supplemented with 1 mM GTP and 10% glycerol. Unseeded
reactions were agitated at 1,400 r.p.m. (for NM) or 700 r.p.m. (for
Sup35) in a thermomixer (Eppendorf) for the indicated time at
25uC. Seeded assembly was unagitated and performed for the
indicated time at 25uC. The amount of seed is indicated as % (wt/
wt). In some experiments (Figure 7A), NM fibers (5 mMN M
monomer)werepretreatedfor60 minat25uCwithoutorwith BSA,
Hsp26, or Hsp42 (10 mM). NM fibers were then recovered by
centrifugation at 16,000 g, gently washed (without resuspending the
pellet), and then resuspended in AB. Ex vivo Sup35 prions for
seeding experimentswereisolated as described [75] and the amount
of Sup35 in the isolated fraction was determined by immunoblot in
comparison to known quantities of pure Sup35. Rnq1 fibers were
assembled as described [74]. For assembly reactions containing
Ssa1:Sis1 or Ssa1:Ydj1, ATP was added (5 mM) plus an ATP
regeneration system comprising creatine phosphate (40 mM) and
creatine kinase (0.5 mM). The extent of fiber assembly was
determined by ThT fluorescence, electron microscopy, or by the
amount of SDS-resistant NM as described [49,55].
Tracking Amyloidogenic NM Oligomers
The oligomer-specific A11 antibody was used to detect
amyloidogenic NM oligomers by ELISA as described [69].
Importantly, Hsp26 and Hsp42 did not cross-react with A11.
Figure 13. sHsps promote gradual depolymerization of Sup35 prions by Hsp110, Hsp70, and Hsp40. (A) Schematic illustrating the
concept of NM-his capped NM fibers (left) or NM capped NM-his fibers (right). Cyan circles depict NM-his and white circles depict NM. (B, C) NM fibers
with NM-his caps (2.5 mM monomer) were not sonicated and incubated at 25uC for 0–28 d in the absence or presence of Hsp26 (5 mM), Ssa1:Sis1
(2.5 mM each), Ssa1:Ydj1 (2.5 mM each), Sse1:Ssa1:Ydj1 (1.67 mM each), or Sse1:Ssa1:Sis1 (1.67 mM each). At the indicated times, reactions were
centrifuged at 436,000 g for 30 min. The amount of SDS-soluble untagged NM (B) or NM-his (C) in the supernatant was then determined by
quantitative immunoblot. Values represent means6SD (n=3). (D, E) NM-his fibers with NM caps (2.5 mM monomer) were not sonicated and
incubated at 25uC for 0–28 d in the absence or presence of Hsp26 (5 mM), Ssa1:Sis1 (2.5 mM each), Ssa1:Ydj1 (2.5 mM each), Sse1:Ssa1:Ydj1 (1.67 mM
each), or Sse1:Ssa1:Sis1 (1.67 mM each). At the indicated times, reactions were centrifuged at 436,000 g for 30 min. The amount of SDS-soluble
untagged NM (D) or NM-his (E) in the supernatant was then determined by quantitative immunoblot. Values represent means6SD (n=3). (F, G) NM-
his fibers with NM caps (2.5 mM monomer) were sonicated and incubated at 25uC for 0–28 d in the absence or presence of Hsp26 (5 mM), Ssa1:Sis1
(2.5 mM each), Ssa1:Ydj1 (2.5 mM each), Sse1:Ssa1:Ydj1 (1.67 mM each), or Sse1:Ssa1:Sis1 (1.67 mM each). At the indicated times, reactions were
centrifuged at 436,000 g for 30 min. The amount of SDS-soluble untagged NM (F) or NM-his (G) in the supernatant was then determined by
quantitative immunoblot. Values represent means6SD (n=3). (H, I) NM fibers (2.5 mM) were sonicated and then incubated for 1 h at 25uC with buffer,
Hsp26, or Hsp42 (10 mM). (H) Sse1:Ssa1:Sis1 (1.67 mM each) or (I) Sse1:Ssa1:Ydj1 (1.67 mM each) was then added and fibers were incubated for 0–28 d
at 25uC. At the indicated times, reactions were centrifuged at 436,000 g for 30 min. The amount of SDS-soluble NM in the supernatant was then
determined by quantitative immunoblot. Values represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g013
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PLoS Biology | www.plosbiology.org 19 June 2012 | Volume 10 | Issue 6 | e1001346Figure 14. Human HspB5 promotes gradual depolymerization of a-syn fibers by human Hsp110, Hsp70, and Hsp40. (A, B) a-Syn fibers
(2.5 mM monomer) were sonicated and then incubated for 0–30 d at 25uC with either buffer, Hsc70 (10 mM), Hdj1 (10 mM), Apg-2 (10 mM), HspB5
(10 mM), Hsc70:Hdj1 (5 mM of each), Hsc70:Apg-2 (5 mM of each), Hsc70:HspB5 (5 mM of each), Hdj1:Apg-2 (5 mM of each), Hdj1:HspB5 (5 mM of each),
Apg-2:HspB5 (5 mM of each), Hsc70:Hdj1:Apg-2 (3.3 mM of each), Hsc70:Apg-2:HspB5, Hsc70:Hdj1:HspB5, Hdj1:Apg-2:HspB5 (3.3 mM of each), or
Hsc70:Hdj1:Apg-2:HspB5 (2.5 mM of each). At the indicated times, reactions were centrifuged at 436,000 g for 30 min (A). The amount of a-syn in the
supernatant was then determined by quantitative immunoblot (A). Alternatively, fiber integrity was assessed by ThT fluorescence (B). Values
represent means6SD (n=3). (C) a-Syn fibers with his-a-syn caps (2.5 mM monomer) were not sonicated and incubated at 25uC for 0–30 d in the
presence of Hsc70:Hdj1:Apg-2:HspB5 (2.5 mM of each). At the indicated times, reactions were centrifuged at 436,000 g for 30 min. The amount of his-
a-syn (blue) or untagged a-syn (red) in the supernatant was then determined by quantitative immunoblot. Values represent means6SD (n=3). (D)
Preformed amyloid fibers composed of a-syn (0.5 mM monomer) were incubated for 6 h at 37uC in buffer plus ATP (5 mM) and ATP-regeneration
system without or with the indicated combination of HspB5 (10 mM), Hsc70 (10 mM), Hdj1 (10 mM), and Apg-2 (10 mM) in the absence (blue bars) or
presence of Hsp104 (2.5 mM, red bars; or 10 mM, green bars). Fiber integrity was then determined by sedimentation analysis and quantitative
immunoblot. Values represent means6SD (n=3).
doi:10.1371/journal.pbio.1001346.g014
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For NM disassembly reactions, NM (5 mM) was assembled with
agitation for 6 h in AB as described above. Wild-type or A53T a-
syn fibers were assembled as described [54]. Polyglutamine (GST-
Q62) (10 mM) was incubated for 1 h at 25uC with thrombin in
AB to separate GST from Q62, and then incubated for a
subsequent 16 h with agitation to generate fibers. Q62 fibers
were recovered by centrifugation and resuspended at 5 mM.
‘‘Capped’’ NM fibers (Figure 13A) were generated by incubating
preformed NM fibers (2.5 mM monomer) with NM-his (5 mM),
and the seeding reaction was allowed to proceed until 50% of
NM-his had been converted to amyloid. This was verified
empirically by determining the amount of SDS-resistant NM-his
by quantitative immunoblot using an anti-Penta-His antibody in
comparison to known quantities of NM-his. Fibers were
recovered by centrifugation and washed (without resuspending
the pellet) prior to disassembly reactions. Capped a-syn fibers
were generated in the same way.
Assembled NM, a-syn, or Q62 fibers (0.5–2.5 mM monomer)
were then incubated in AB with the indicated components and
times (refer to figure legends). ATP was added (5 mM) plus an
ATP regeneration system comprising creatine phosphate
(40 mM) and creatine kinase (0.5 mM). For long-term incuba-
tions (Figures 12–14), reactions were conducted in AB supple-
mented with sodium azide (0.001%) and protease inhibitors
(Complete, Roche). Sodium azide and protease inhibitors were
removed by dialysis prior to transformation into yeast cells. For
short-term incubations (Figure 11), sodium azide and protease
inhibitors were omitted. Immunoblot analysis confirmed that for
long-term incubations the total amount of NM or a-syn
remained constant throughout the incubation. Fiber disassembly
was assessed by ThT fluorescence, electron microscopy, or by
sedimentation analysis (436,000 g for 10 min at 25uC) followed
by determination of the amount of SDS-soluble protein in the
supernatant or the amount of protein in the pellet fraction by
quantitative immunoblot [49,54,55,61]. For disassembly of
‘‘capped’’ NM or a-syn fibers, an anti-Penta-His antibody
(Qiagen) was used to detect the his-tagged protein, which
migrates slower than untagged protein by SDS-PAGE. Thus,
untagged and his-tagged protein could be readily distinguished
and quantified in comparison to know amounts of untagged or
his-tagged protein.
Disaggregation of Heat-Denatured Firefly Luciferase
Luciferase reactivation was performed as described [33].
Briefly, aggregation of firefly luciferase was elicited by heating
at 45uC for 15 min in the absence or presence of indicated
concentrations of Hsp26 or Hsp42. Aggregates were then
incubated in the presence of Hsp104, Ssa1, and Ydj1.
Luciferase reactivation was assessed using the luciferase assay
system (Promega).
Acrylodan and Pyrene Fluorescence
Acrylodan and pyrene fluorescence were measured as described
[40].
Thermal Stability of NM Fibers
The thermal stability of NM fibers (Figure 10A) was determined
by incubation of fibers at increasing temperatures (25uC to 100uC
in 10uC intervals) for 5 min in 1.6% SDS, followed by SDS–
PAGE and quantitative immunoblot to determine the amount of
SDS-soluble NM [44].
Protein Transformation
Yeast cells from a W303-derived strain (MATa leu2-3, -112 his3-
11 trp1-1 ura3-1 ade1-14 can1-100 [rnq
2][ psi
2][ ure-o]) that
contained an ADE1 nonsense mutation suppressible by [PSI
+]
were transformed with the indicated NM or Sup35 conformers
and a URA3 plasmid. The proportion of Ura
+ transformants that
acquired [PSI
+] was determined as described [44,49]. For
transformations into [psi
2] yeast cells expressing high levels of
the indicated combination of Hsp26, Hsp42, Sis1, and Ydj1, a
HIS3 or LEU2 plasmid was utilized.
[PSI
+] Induction
Dhsp26, Dhsp42,o rDhsp26Dhsp42 yeast strains were as described
[33]. Yeast cells from a W303-derived strain (MATa leu2-3, -112
his3-11 trp1-1 ura3-1 ade1-14 can1-100 [RNQ
+][ psi
2]) were
transformed with plasmids for the overexpression of Hsp26,
Hsp42, Ydj1, and Sis1 together with a plasmid for the
overexpression of NM fused to the yellow fluorescent protein
(NM-YFP) or Sup35. All the chaperone constructs were in
2 micron plasmids under the control of the constitutive GPD
promoter for high expression. The NM-YFP or Sup35 construct
was under the control of the inducible Gal1 promoter. Four
colonies of each of the transformants were restreaked on fresh
selective plates. Only colonies that presented the correct color for
[psi
2], [PIN
+] cells (i.e., red colonies) were chosen. For each [PSI
+]-
induction experiment at least three independent transformants
were incubated in three replicates each in 3 ml of selective liquid
medium containing glucose as the sole carbon source overnight.
The next day, the yeast cells were washed three times with sterile
water before transferring them to selective liquid media containing
galactose as the sole carbon source. The cells were incubated in
the galactose media for 4 h (for NM-YFP) or 16 h (for Sup35) at
30uC before they were diluted to an OD600 of 0.002 and 80 mlo f
these diluted cultures were evenly plated on 25% YPD plates. The
plates were then incubated for 3 d at 30uC followed by an
overnight incubation at 4uC for better color development. [PSI
+]
induction was scored as the number of white and pink ([PSI
+]
colonies) ADE
+ colonies divided by the total number of colonies.
Microscopy
Three independent yeast transformants expressing the indicated
chaperones together with NM-YFP were incubated overnight in
liquid selective media containing glucose as the sole carbon source.
The next day, the cells were recovered and washed three times
with sterile water and then transferred to selective liquid media
containing galactose as the sole carbon source. Cells were
incubated for 4 h at 30uC and then inspected by fluorescence
microscopy using a Nikon Eclipse 300 microscope with the
appropriate filters.
[PSI
+] Curing
Yeast cells from a W303-derived strain (MATa leu2-3, -112 his3-
11 trp1-1 ura3-1 ade1-14 can1-100 [rnq
2][ PSI
+]) were transformed
with plasmids for the overexpression of Hsp26, Hsp42, or Hsp104.
All these constructs were in 2 micron plasmids under the
expression control of the constitutive GPD promoter for high
expression. Four colonies of each of the transformants were
restreaked on fresh selective plates. Only colonies that presented
the correct color for [PSI
+] cells (i.e., white colonies) were chosen.
For each [PSI
+]-curing experiment at least three independent
transformants were incubated in three replicates each in 3 ml
selectiveliquid medium containingglucose asthesole carbonsource
overnight. The next day, the cultures were diluted to an OD600 of
sHsps Potentiate Amyloid Dissolution
PLoS Biology | www.plosbiology.org 21 June 2012 | Volume 10 | Issue 6 | e10013460.2 and incubated for 6 h. The yeast cultures were then diluted to
an OD600 of 0.002 and 80 ml of these diluted cultures were spread
on 25% YPD plates (resulting in ,700 colonies per plate). The
plates were then incubated for 3 d at 30uC followed by an overnight
incubation at 4uC for better color development. [PSI
+] curing was
scored as the proportion of red ade
2 [psi
2] colonies.
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